CDT Equity Inc. (CDT) vs Notable Labs, Ltd. (NTBLQ)

CDT Equity Inc. and Notable Labs, Ltd. are both Biotechnology companies. CDT Equity Inc. and Notable Labs, Ltd. are of similar size ($2.4M and $2.4M). Notable Labs, Ltd. has the higher net margin (6,350.6% vs 0.00%) and the lower return on invested capital (−295.4% vs −21.3%). Across the 12 metrics below, CDT Equity Inc. leads on 7 and Notable Labs, Ltd. on 5.

Valuation

Metric CDT NTBLQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.25 0.74
EV/Sales n/m 23.30 10.73
Earnings yield 167,728,033.38% 0.00% (28.84%)
Free cash flow yield (278,822.70%) 0.00% (23.03%)

Profitability

Metric CDT NTBLQ Biotechnology median
Gross margin — 116.87% 65.16%
Operating margin 0.00% 9,259.04% 0.00%
Net margin 0.00% 6,350.60% 0.00%
Free cash flow margin 0.00% 9,158.43% 0.00%
Return on equity (69.68%) (79.79%) (57.72%)
Return on assets (55.16%) (59.14%) (49.22%)
Return on invested capital (21.28%) (295.36%) 0.00%

Growth

Metric CDT NTBLQ Biotechnology median
Revenue growth (TTM) — (129.02%) 5.64%
EPS growth (last fiscal year) 98.09% 84.47% —
Revenue growth, 5-year CAGR — (11.93%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT NTBLQ Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 0.13 2.77 4.73
Net debt to EBITDA 0.05 0.80 0.96

Dividend

Metric CDT NTBLQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CDT NTBLQ Biotechnology median
Market cap 2.41m 2.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack